When it comes to drugs, politicians agreed: Cannabis should be legalized. Mind you, for medical use. In Switzerland has passed the Motion Kessler in the previous year, the Council of States and national Council. Now the Federal Council on the train to write the law.

In Israel, has voted in February, a clear majority of the Knesset, with no votes against for the legal cultivation and Export of cannabis. The Cannabis industry has boomed prior to the recent Initiatives in both countries, partly under unclear legal conditions. Now you experienced your first High.

Compete for billions of market

Cannabis is smeared on the skin, in cigarette smoke to fall Asleep and pain in DRIBs and drabs swallowed – the applications are endless. What the industry is interested in, but most of all, are medical products with the active ingredient Cannabidiol (CBD). Here is a multi-billion industry grows around the world. Particularly in small, innovative countries, Switzerland and Israel: the Startup-savvy, research-intensive, business-friendly, liberal.

dozens of companies in Switzerland, hundreds in Israel and work together and against each other on new drugs with CBD for the treatment of cancer, Parkinson’s disease, Multiple sclerosis, or epilepsy and to work at the legal marketing for the medical and beverage industries.

Sales potential of 5 billion Swiss francs

According to forecasts, the market rising potential in the next five years, to over 60 billion dollars worldwide. Israel and Switzerland screws to your paragraphs, to make a part of this billion not to be missed. The sales potential for the Swiss Cannabis industry is estimated according to the European cannabis report to up to 5 billion Swiss francs.

The Israeli Ministry of health expects $ 1 billion in revenue only for the Export of medical Cannabis, regardless of the upstream and downstream Agricultural and pharmaceutical industries. And regardless of the Recreational use of cannabis, for food, tobacco and cosmetics.

In Switzerland, even Big Pharma already into the Cannabis Business started: Novartis over the generic Sandoz division, a strategic partnership with Tilray, a pharmaceutical and Cannabis producers in Canada Nanaimo. Canada is a particularly interesting market, because the country is one of the first in the world, the Cannabis has been completely released.

The agreement in Canada includes a “global framework agreement allows for a possible collaboration in all countries of the world, subject to country-specific conditions,” says a Novartis spokesperson. The United States also are an attractive target market with a potential in the tens of billions. Americans enjoy Cannabis, in the meantime, rather than ice cream or movies.

Who liberalised faster, wins

The rivalry of the two countries ‘ world market shares in the highly competitive Cannabis market reached a climax. Only the one who creates fast liberal laws and the necessary environment for Pharma, start-UPS and farmers, will secure for its export industry a piece of cake. Currently, Israel has in its legislation, the nose in front, the pace of liberalisation is faster than in Switzerland.

Also on the company’s side: The inhaler manufacturer Syqe threw 50 million dollars and has a partnership with the Israeli pharmaceutical company Teva, the Cannabis company, Intercure raised $ 12 million, Gemmacert 2.25 million. Medivie completed an Cannabis-export deal, about $ 110 million, Innocan Pharma 800 000 dollars secured via Crowdfunding.

“Immobilienmogule and diamond dealers to throw me the money and say invest for me in hemp, no matter where, the main thing I am with the Trend,” says the hemp expert and Investment Advisor, Inbar Maymon-Pomeranchik. The biotechnology and login consulting company Biodiligence is a mediator between science and the economy: “The a’s talk Science, the other Money.”

CBD makes the Swiss company Hyper active

On dozens of hectares, is made in Israel, cannabis is already for the Export of Europe. The main target market for both Israel and Switzerland in Europe. It rushes, have also been recognised by politicians and companies in Switzerland. Slowly, but surely, the confederates following suit.

Local farmers plant on several dozen hectares of cultivation area, the revenue generating “Grass”. For food, soft drinks, beer, tinctures, medicine-related products and smoke. Swiss farmers already dream of up to 500 hectares of cultivation area in the coming months and years.

The Swiss company’s Pure, Tellement Facile and Creso Pharma experimenting with Cannabis, grow cannabis, want to have their products patented and build global business models from seed to pill. The Geneva Pharmotech conducts research on antibiotic with CBD and performs clinical trials at the University hospital of Lausanne. The Ticino-based company Crystal Hemp has a CBD product in the offer, which was accepted by Swissmedic in Switzerland.

Research farm in Tenerife

Crystal Hemp business, as a Swiss company in the Cannabis-particularly resourceful. “We have prepared the CBD Chapter for us, now we want to push the development of THC products,” says Board of Directors Amos Radian. His announcement has caused the Swiss Israel Medical Cannabis Summit in January in Zurich for attention. Since CBD is the active ingredient of the hemp plant, which is classified by health experts as therapeutic.

the UN and the WHO want to upgrade the CBD of the level of anesthetic to the level of medicinal active ingredient – a Revolution for the Cannabis industry on the path to becoming a legal business environment. THC is what makes high, as (entry-level)drug a bad reputation in most countries of the world prohibited. In Switzerland, the THC content in hemp products higher than 1 percent.

to make but also THC as a pharmaceutical active ingredient, salon, Radian Crystal Hemp, a plant and a laboratory area of 5000 square meters for research in a special economic zone on the island of Tenerife bought. “We have only a few percent corporate tax, and three projects in parallel: for hemp farming in the glass house, a packing plant and a laboratory,” says the enterprising Crystal-Hemp-in-chief. Inaction you can’t accuse the Swiss entrepreneurs in the Cannabis Business certainly.

Is China a major power in the Cannabis Business?

Israel and Switzerland are now on a par when it comes to the business opportunities with Cannabis. For the remote location of Israel, the Export and logistics costs to Europe are higher. “The work is in the closer in Europe, located in Switzerland is more expensive,” says Adam Dozetas, a Partner in the Tel Aviv consulting firm Shibolet.

The lawyer knows both the economic conditions as well as the Legal positions of both countries and companies on call now beiderorts to cooperate in research and marketing, as long as the market is still young and barely occupied. Because with more and more liberalised markets, and rising demand, companies and people are starting economies to interest in it, of which you heard so far, nothing from China.

The Asian giant is a hemp Superpower, which established the Plant for the textile industry and on 600 hectares in the North of China, the world’s largest hemp operates fields. What consultants Dozetas therefore warns, are more than 600 patent applications for the medical use of cannabis, which will come according to his records from China and hardly any in the industry are noticed.

Four Chinese companies, there are already, which as of today, pure CBD can recover. China would be not only for the most cost-effective suppliers of hemp, but also almost self-sufficient for its own pharmaceutical industry, farming and small countries such as Switzerland and Israel from the outside.

(Latin), and hemp (German) are two terms for the same Plant. This leaves, seeds and Oil can be used. The two main sub-species Cannabis sativa and Cannabis indica. The resin of the female flowers of the Indian hemp is referred to as hashish. the marijuana ( Grass ) is plants in contrast, from the dried flowers and leaves of the female hemp.

In marijuana, are included in 113 of the cannabinoids. The most famous of these active ingredients Tetrahydrocannabinol (THC) and Cannabidiol ( CBD ).

is illegal in most countries, because it has an intoxicating effect. In Switzerland the cultivation of Cannabis with THC is allowed up to a per cent since 2011. Products are delivered to the food act (tobacco regulation) and the narcotics act. The substance should also have a pain and anti-inflammatory effect. Producers may, however, make no promise of healing. In the flowers of the THC is at its strongest. Depending on the breeding, the THC content can be up to 20 percent.

CBD is now very well known. In contrast to THC, this causes no “High”. It is allowed in many countries. Often, the CBD is taken as an Oil or tea. It should help with anxiety and depression.